Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Short Interest Update

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) was the recipient of a significant decline in short interest in January. As of January 30th, there was short interest totaling 37,632 shares, a decline of 78.4% from the January 15th total of 174,589 shares. Based on an average daily volume of 211,541 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.7% of the company’s stock are sold short. Currently, 0.7% of the company’s stock are sold short. Based on an average daily volume of 211,541 shares, the days-to-cover ratio is presently 0.2 days.

Institutional Investors Weigh In On Baird Medical Investment

Several hedge funds have recently bought and sold shares of BDMD. Geode Capital Management LLC grew its stake in shares of Baird Medical Investment by 59.7% in the second quarter. Geode Capital Management LLC now owns 25,442 shares of the company’s stock valued at $93,000 after acquiring an additional 9,511 shares in the last quarter. Jane Street Group LLC bought a new position in Baird Medical Investment in the second quarter valued at approximately $142,000. Finally, Citadel Advisors LLC bought a new position in shares of Baird Medical Investment in the 3rd quarter valued at $99,000. 19.78% of the stock is currently owned by institutional investors and hedge funds.

Baird Medical Investment Stock Down 10.0%

Shares of NASDAQ:BDMD traded down $0.10 during mid-day trading on Tuesday, reaching $0.91. 158,004 shares of the stock were exchanged, compared to its average volume of 134,429. Baird Medical Investment has a one year low of $0.89 and a one year high of $7.26. The stock’s 50 day simple moving average is $1.26 and its 200-day simple moving average is $1.68.

Analyst Ratings Changes

Several research firms recently issued reports on BDMD. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Baird Medical Investment in a report on Tuesday, January 27th. Wall Street Zen raised Baird Medical Investment from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Baird Medical Investment currently has a consensus rating of “Sell”.

About Baird Medical Investment

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.